Formoterol fumarate is used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults and children 6 years of age and older.

Chronic Obstructive Pulmonary Disease (COPD)

• The dosage of formoterol fumarate depends on the patient's age, severity of the condition, and response to treatment.
• The recommended dosage for adults and children 12 years of age and older with asthma or COPD is 12 mcg twice daily, administered via inhalation using a dry powder inhaler.
• The recommended dosage for children 6 to 11 years of age with asthma is 12 mcg twice daily, administered via inhalation using a dry powder inhaler.
• The maximum daily dosage should not exceed 48 mcg in adults and 24 mcg in children.

Most common adverse reactions are-

• diarrhea
• nausea
• nasopharyngitis
• dry mouth
• vomiting
• dizziness
• insomnia

Diarrhea

Nasopharyngitis

Dry Mouth

Dizziness

• Do not initiate Formoterol Fumarate Inhalation Solution in acutely deteriorating patients.
• Do not use for relief of acute symptoms. Concomitant short-acting beta2-agonists can be used as needed for acute relief.
• Do not exceed the recommended dose.  Excessive use of Formoterol Fumarate Inhalation Solution, or use in conjunction with other medications containing long-acting beta₂-agonists, can result in clinically significant cardiovascular effects, and may be fatal. 
• Life-threatening paradoxical bronchospasm can occur.  Discontinue Formoterol Fumarate Inhalation Solution immediately. 
• Use with caution in patients with cardiovascular or convulsive disorders, thyrotoxicosis, or with sensitivity to sympathomimetic drugs.